 |
|
Risk Factors for Recurrence of Postoperative Trichiasis
Implications for Trachoma Blindness Prevention
Hui Zhang, MS;
Ram P. Kandel, MPH;
Bassant Sharma, MD;
Deborah Dean, MD, MPH
Arch Ophthalmol. 2004;122:511-516.
Background Trachoma is the leading worldwide cause of preventable blindness. Surgery can alleviate trachomatous trichiasis (TT), the blinding sequelae of trachoma, but recurrence rates are high.
Objective To investigate risk factors for TT recurrence.
Methods We conducted a prospective case-control cohort study in Nepal that included patients with TT who were undergoing bilamellar tarsal-rotation surgery and control subjects who have scarring but no TT. Conjunctivae were graded for trachoma and swabbed to detect Chlamydia trachomatis by in-house and commercial (Roche Amplicor; Roche Diagnostics Corp, Indianapolis, Ind)–polymerase chain reaction. Univariate and multivariate analyses were performed for associations with chlamydiae and other risk factors.
Results Postoperative TT recurrence rates were 11.1% (4 cases) at 6 months and 25.0% (11 cases) at 12 months while no controls developed TT. Significantly, 5 (45.5%) of 11 patients with TT recurrences at 12 months had chlamydial infection at baseline (odds ratio, 6.0; 95% confidence interval, 1.5-24.3; P = .01), 8 (72.7%) at 6 months (odds ratio, 28; 95% confidence interval, 4.3-181.0; P <.001), and 9 (81.8%) at 12 months (odds ratio, 48; 95% confidence interval, 7.5-302.6; P = .00). No controls were infected during this time. Active trachoma and the baseline number of eyelashes touching the globe were also risk factors for TT recurrence.
Main Outcome Measures The outcome variable was TT recurrence at 6 and 12 months.
Conclusion To our knowledge, this is the first study to demonstrate that chlamydial infection at the time of surgery and at follow-up is a significant risk factor for postoperative TT recurrence.
From the Children's Hospital Oakland Research Institute, Oakland, Calif (Ms Zhang and Dr Dean); Lumbini Rana-Ambika Eye Hospital, Bhairahawa, Nepal (Mr Kandel and Dr Sharma); and the Department of Medicine, University of California at San Francisco School of Medicine (Dr Dean). The authors have no relevant financial interest in this article.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Trachoma Control: Is Azithromycin the Answer for Trichiasis Too?
Lin and Lietman
Arch Ophthalmol 2007;125:819-820.
FULL TEXT
Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.
Atik et al.
JAMA 2006;296:1488-1497.
ABSTRACT
| FULL TEXT
Impact of oral azithromycin on recurrence of trachomatous trichiasis in Nepal over 1 year
Zhang et al.
Br. J. Ophthalmol. 2006;90:943-948.
ABSTRACT
| FULL TEXT
Single-Dose Azithromycin Prevents Trichiasis Recurrence Following Surgery: Randomized Trial in Ethiopia.
West et al.
Arch Ophthalmol 2006;124:309-314.
ABSTRACT
| FULL TEXT
Trachoma
Chidambaram and Lietman
Br. J. Ophthalmol. 2005;89:1232-1233.
FULL TEXT
A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia
Burton et al.
Br. J. Ophthalmol. 2005;89:1282-1288.
ABSTRACT
| FULL TEXT
Characteristics of trichiasis patients presenting for surgery in rural Ethiopia
Melese et al.
Br. J. Ophthalmol. 2005;89:1084-1088.
ABSTRACT
| FULL TEXT
Long term outcome of trichiasis surgery in the Gambia
Burton et al.
Br. J. Ophthalmol. 2005;89:575-579.
ABSTRACT
| FULL TEXT
Risk Factors for Postsurgical Trichiasis Recurrence in a Trachoma-Endemic Area
West et al.
IOVS 2005;46:447-453.
ABSTRACT
| FULL TEXT
|
